期刊文献+

Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis 被引量:5

Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis
下载PDF
导出
摘要 AIM:To determine the platelet-activating factor (PAF) synthesis and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. METHODS:Kupffer cells, isolated from the livers of control and CCl4-induced cirrhotic rats, were placed in serum-free medium overnight. PAF saturation binding, ET-1 saturation and competition binding were assayed. ET-1 induced PAF synthesis, mRNA expression of PAF, preproendothelin-1, endothelin A (ETA) and endothelin B (ETB) receptors were also determined. RESULTS:A two-fold increase of PAF synthesis (1.42 ± 0.14 vs 0.66 ± 0.04 pg/μg DNA) and a 1.48-fold increase of membrane-bound PAF (1.02 ± 0.06 vs 0.69 ± 0.07 pg/μg DNA) were observed in activated Kupffer cells of cirrhotic rats. The application of ET-1 to Kupffer cells induced PAF synthesis in a concentration-dependent manner in both cirrhotic and normal rats via ETB receptor, but PAF synthesis in the activated Kupffer cells was more effective than that in the normal Kupffer cells. In activated Kupffer cells, PAF receptor expression and PAF binding capacity were markedly enhanced. Activated Kupffer cells raised the [125I]-ET-1 binding capacity, but changed neither the affinity of the receptors, nor the expression of ETA receptor. CONCLUSION:Kupffer cells in the course of CCl4-induced cirrhosis are the main source of increased PAF. ET-1 is involved endogenously in stimulating the PAF synthesis in activated Kupffer cells via ETB receptor by paracrine. ETA receptor did not appear in activated Kupffer cells, which may exacerbate the hepatic and extrahepatic complications of cirrhosis. AIM: To determine the platelet-activating factor (PAF) synthesis and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. METHODS: Kupffer cells, isolated from the livers of control and CCl4-induced cirrhotic rats, were placed in serum-free medium overnight. PAF saturation binding, ET-1 saturation and competition binding were assayed. ET-1 induced PAF synthesis, mRNA expression of PAF, preproendothelin-1, endothelin A (ETA) and endothelin B (ETB) receptors were also determined. RESULTS: A two-fold increase of PAF synthesis (1.42 ± 0.14 vs 0.66 ± 0.04 pg/μg DNA) and a 1.48-fold increase of membrane-bound PAF (1.02 ± 0.06 vs 0.69 ± 0.07 pg/μg DNA) were observed in activated Kupffer cells of cirrhotic rats. The application of ET-1 to Kupffer cells induced PAF synthesis in a concentration-dependent manner in both cirrhotic and normal rats via ETB receptor, but PAF synthesis in the activated Kupffer cells was more effective than that in the normal Kupffer cells. In activated Kupffer cells, PAF receptor expression and PAF binding capacity were markedly enhanced. Activated Kupffer cells raised the [^125I]-ET-1 binding capacity, but changed neither the affinity of the receptors, nor the expression of ETA receptor. CONCLUSION: Kupffer cells in the course of CCl4- induced cirrhosis are the main source of increased PAF. ET-1 is involved endogenously in stimulating the PAF synthesis in activated Kupffer cells via ETB receptor by paracrine. ETA receptor did not appear in activated Kupffer cells, which may exacerbate the hepatic and extrahepatic complications of cirrhosis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第5期764-770,共7页 世界胃肠病学杂志(英文版)
基金 the Major Science and Technology Research Fund of the National 863 Program, No. 2003AA208106 the Fund for Outstanding Medical Scientists of PLA, No. 04J020
关键词 肝硬化 症状 动物模型 临床治疗 Platelet activating factor Kupffer cells Receptor Cirrhosis
  • 相关文献

参考文献2

二级参考文献64

  • 1马雪梅,王春平,韩军,向轶,苏淑慧,冯永毅,杨永平.肝硬化形成过程中血小板活性因子及其受体在门脉高压形成中的意义[J].解放军医学杂志,2004,29(12):1062-1064. 被引量:6
  • 2[1]Chao W,Olson MS.Platelet-activating factor:receptors and signal transduction.Biochem J 1993; 292 (Pt 3):617-629
  • 3[2]Montrucchio G,Alloatti G,Camussi G.Role of platelet-activating factor in cardiovascular pathophysiology.Physiol Rev 2000; 80:1669-1699
  • 4[3]Prescott SM,Zimmerman GA,Stafforini DM,McIntyre TM.Platelet-activating factor and related lipid mediators.Annu Rev Biochem 2000; 69:419-445
  • 5[4]Snyder F.Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.Am J Physiol 1990; 259:C697-C708
  • 6[5]Buxton DB,Shukla SD,Hanahan DJ,Olson MS.Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine.J Biol Chem 1984; 259:1468-1471
  • 7[6]Hines KL,Braillon A,Fisher RA.PAF increases hepatic vascular resistance and glycogenolysis in vivo.Am J Physiol 1991;260:G471-G480
  • 8[7]Kleber G,Braillon A,Gaudin C,Champigneulle B,Cailmail S,Lebrec D.Hemodynamic effects of endotoxin and plateletactivating factor in cirrhotic rats.Gastroenterology 1992; 103:282-288
  • 9[8]Tanaka S,Kasuya Y,Masuda Y,Shigenobu K.Studies on the hypotensive effects of platelet activating factor (PAF,1-Oalkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats,guinea pigs,rabbits,and dogs.J Pharmacobiodyn 1983; 6:866-873
  • 10[9]Thirunavukkarasu C,Yang Y,Subbotin VM,Harvey SA,Fung J,Gandhi CR.Endothelin receptor antagonist TAK-044arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.Gut 2004; 53:1010-1019

共引文献6

同被引文献61

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部